Welcome to the IDT family!

Your product is now available from Integrated DNA Technologies.

Many of the Swift products you have grown to love are now part of our new complete portfolio, xGen™ NGS. Through this new partnership we are pleased to offer you comprehensive next generation sequencing solutions.

xGen NGS—made for you.

Unsure of what products are available? Or, perhaps you’d like guidance on which products are compatible? If so, try our xGen NGS Solutions Builder Tool today.

Welcome to the IDT family!

Find Archer now at IDT!

All Archer information is now available on IDT’s website. You can view Archer assays alongside IDT’s xGen™ NGS portfolio to find the best next generation sequencing solution for your lab.

Confidently detect more with Archer NGS assay solutions for your solid tumor, blood cancer, immune profiling, and genetic disease research.

Explore how our NEW cGMP gRNA manufacturing service can accelerate your CRISPR therapeutics project

More posts in DECODED

  • Applications and benefits of CRISPR functional genomics screens using arrayed guide RNA libraries
  • Protocols for CRISPR genome editing in your model system
  • Using CRISPR-Cas9 technology for targeted nanopore sequencing
  • <em>The CRISPR Basics Handbook</em>: An IDT publication to help you learn CRISPR
  • SHERLOCK, PAC-MAN, and more: How CRISPR-Cas13 enzymes may be useful in the COVID-19 pandemic and beyond
  • Alt-R™ HDR Donor Blocks can enable long DNA knock-ins while decreasing undesired edits
  • Cloning strategies: Cohesive end cloning
  • SUN™ fluorophore
  • Tips for working with IDT Gene Fragments
  • Genome Oligopaint: Painting a clearer picture with oPools™ Oligo Pools
  • A modification that facilitates oligonucleotide uptake into cells
  • CRISPR-based depletion of unwanted sequences improves targeted next generation sequencing
  • Improving efficiency of homology-directed repair (HDR)
  • Using molecular modeling to identify key structures for HCV neutralizing antibodies
  • Site-directed mutagenesis—Improvements to established methods
  • gBlocks™ Gene Fragments used in an antibody discovery workflow to test the efficiency of tumor-reactive antibodies
  • Characterization of antitumor CD8<sup>+</sup> T cells in melanoma to optimize immune response
  • A fast, cost-effective alternative to radiolabeling and HPLC/MS for measuring dNTPs
  • Site-directed mutagenesis methods
  • Antisense Oligonucleotides (ASOs)
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8 (current)
  • 9